Results 131 to 140 of about 12,045 (194)

Facing multidrug-resistant pathogens in periprosthetic joint infections with self-administered outpatient parenteral antimicrobial therapy

, 2020
A key factor in the successful management of periprosthetic joint infection (PJI) besides the surgical regime is a consistent antimicrobial therapy. Recently, oral versus intravenous (IV) antibiotics for bone and joint infection trial demonstrated the ...
Hanusrichter, Yannik (Dr. med.), Geßmann, Jan (Prof. Dr. med.), Frieler, Sven (Dr. med.), Schildhauer, Thomas Armin (Prof. Dr. med.), Baecker, Hinnerk (PD Dr. med.), Bellova, Petri (Dr. med.)   +5 more
core  

Put the Vanc Down, Flip It and Reverse It: Comparison of Vancomycin and Daptomycin Health Care Utilization and Cost in Outpatient Parenteral Antimicrobial Therapy

Vancomycin and daptomycin are frequently used in outpatient parenteral antimicrobial therapy (OPAT). We analyze health care utilization and cost to the health care system for vancomycin vs daptomycin in the outpatient setting and find that vancomycin ...
Young, Kathleen, Lewis II, James S., Sikka, Monica K., Luis, Katie, Streifel, Amber C., Douglass, Alyse, Nakrani, Monark, Varley, Cara D., Mayer, Heather, Yu, Diana   +9 more
core   +1 more source

Challenges and drivers in the implementation of current practices in outpatient parenteral antimicrobial therapy: an international survey. [PDF]

JAC Antimicrob Resist
Mohammed SA, Roberts JA, Nicolás D, Aslan AT, Senok A, Aldabal L, Erku D, Nor ANM, Pollard J, Cotta M, Seaton RA, Gilchrist M, Sime FB.   +12 more
europepmc   +1 more source

Oral vs. outpatient parenteral antimicrobial treatment for infective endocarditis: study protocol for the spanish oralPAT‑IE GAMES Trial

Introduction The POET trial demonstrated that moving from intravenous to oral antibiotics in stable patients with left-sided infective endocarditis (IE) was noninferior to fully parenteral treatment.
OraPAT-IE GAMES Investigators, Cuervo, Guillermo, López-Lirola, Ana, Luque-Marquez, Rafael, Alonso-Socas, María M., Araji Tiliani, Omar, Hernández-Meneses, Marta, López-Cortés, Luis E., de Cueto López, Marina, Alarcón, Arístides de   +9 more
core   +1 more source

Cost savings of outpatient parenteral antimicrobial therapy using a digital infusion pump. [PDF]

JAC Antimicrob Resist
Helleren R, Jacobsen M, Theisen T, Moe CE, Opsal A, Trønnes R, Skogen V, Gallefoss F.   +7 more
europepmc   +1 more source

Challenges for the implementation of an outpatient parenteral antimicrobial therapy clinic system in Mexico. [PDF]

IJID Reg
Nuzzolo-Shihadeh L, Camacho-Ortiz A.
europepmc   +1 more source

Evaluation of a Remote Therapeutic Monitoring Device and Integrated Care Platform in Outpatient Parenteral Antimicrobial Therapy. [PDF]

Clin Infect Dis
Siegrist EA, Berenson M, Dvorak JD, Dozier JK, Wannier SR, Dib RW, Scott BM, Ibragimova N, Meyer DN, Alkozah M, Salvaggio M, White BP, Siddique B, Thind S, Bratzler DW, Sassine J.   +15 more
europepmc   +1 more source

Early Experience With Beta-Lactam Therapeutic Drug Monitoring in an Outpatient Parenteral Antimicrobial Therapy (OPAT) Program. [PDF]

Open Forum Infect Dis
Barrett KO, Rivera CG, Abu Saleh O, Pertzborn M, Ausman SE, Rule AD, Arensman Hannan K, Stevens RW, Barreto EF.   +8 more
europepmc   +1 more source

Patients referred to but not taken on to an outpatient parenteral antimicrobial therapy (OPAT) service: the impact of infection specialist advice on the assessment and clinical outcomes. [PDF]

JAC Antimicrob Resist
Rimbi M, Pybus S, Dodds S, White B, Ritchie N, Seaton RA.   +5 more
europepmc   +1 more source

Evaluating Outpatient Parenteral Antimicrobial Therapy (OPAT) Clinic for Pediatric Infectious Conditions: Insights From Alberta Children's Hospital. [PDF]

Can J Infect Dis Med Microbiol
Alsharrah D, Jadavji T.
europepmc   +1 more source